Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "novel transcript, antisense to zinc finger protein 609 (ENSG00000310198, LOC101930091)" is an uncharacterized non-coding RNA that is transcribed from the opposite DNA strand of the ZNF609 gene. Unlike the well-studied ZNF609 (protein-coding) and circ-ZNF609 (circular RNA), there is little information regarding the sequence, expression, or biological relevance of this antisense transcript. It appears in genome annotations based on transcriptome sequencing but is not referenced in the functional genomics literature, and is not currently considered a validated molecular target for therapy or diagnostics. The vast majority of research about ZNF609 involves either its protein-coding transcript or its circular RNA, which acts as a microRNA sponge and may be translated in some cell types[1][3]. The transcript ENSG00000310198 (LOC101930091) does not have reported biological functions, disease associations, or drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to Zinc finger protein 609.